Overweight: Clinical Trials

33 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 terminated. 33 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 433Terminated 33

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeting the Gut-brain Axis to Facilitate Weight Loss in High Fat Diet Consumers
RiduZone (90% OEA), Placebo - Overweight and Obesity
Phase 4TerminatedYale University642021-04-062025-01-10
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
Weight Management Program (WMP), Traditional care, Phentermine / Topiramate Extended Release Oral Capsule - Type 2 Diabetes, Obesity
Phase 4TerminatedThe Cleveland Clinic742020-09-012024-09-19
Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients
Dulaglutide Injection, Saline Injection - Stress Hyperglycemia
Phase 4TerminatedEmory University282019-03-082024-05-30
Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy
Administration of weight loss drug (Metformin or Topiramate) - Obesity
Phase 4TerminatedHartford Hospital122019-03-012023-02-14
Acute Labetalol Use in Preeclampsia
Experimental labetalol dose, Current standard of care - Preeclampsia With Severe Features
Phase 4TerminatedAlbany Medical College152019-02-182020-07-22
The Effect of Two Aspirin Dosing Strategies for Obese Women at High Risk for Preeclampsia
162mg aspirin dose - Preeclampsia
Phase 4TerminatedOhio State University1522019-01-152024-04-29
Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
Albuterol Sulfate, Interval Warm-up exercise - Asthma in Children, Obesity, Childhood
Phase 4TerminatedUniversity of Nevada, Las Vegas342018-09-182021-07-22
Metabolic Effects of Natriuretic Peptide Hormones
recombinant human BNP(1-32), placebo (control, normal saline) - Obesity, Cardiovascular Physiological Phenomena
Phase 4TerminatedVA Office of Research and Development52018-07-012024-11-25
Predictors of Lorcaserin-Induced Weight Loss
Belviq, Placebo - Overweight and Obesity
Phase 4TerminatedColumbia University322018-01-032024-03-27
Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years
lorcaserin hydrochloride XR, Placebo - Obesity
Phase 4TerminatedEisai Inc.2782017-09-282021-07-19
CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes
canagliflozin, Placebo (for canagliflozin) - Diabetes Mellitus, Type 2, Obesity
Phase 4TerminatedThe Cleveland Clinic162017-01-052020-11-20
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
Lorcaserin, Metformin, Placebo - Schizophrenia, Schizoaffective Disorder
Phase 4TerminatedUniversity of North Carolina, Chapel Hill712016-09-012021-03-03
Liraglutide for HIV-associated Neurocognitive Disorder
Liraglutide - HIV Infection, Diabetes Mellitus Type 2
Phase 4TerminatedTemple University42016-09-012022-07-29
Naltrexone/Bupropion Cardiovascular Outcomes Study
Naltrexone HCl/Bupropion HCl ER, Placebo - Obesity, Cardiovascular Diseases
Phase 4TerminatedOrexigen Therapeutics, Inc672016-01-012017-02-27
Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy
Ketofol, Propofol, Saline - Obesity, Bariatrics
Phase 4TerminatedIcahn School of Medicine at Mount Sinai222016-01-012020-02-11
Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients
Nephro Check Test, serum creatinine measurement - Acute Kidney Injury, Arterial Hypertension
Phase 4TerminatedUniversitair Ziekenhuis Brussel1002015-04-012018-10-15
Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
Liraglutide, Observation alone - Type 2 Diabetes, Overweight
Phase 4TerminatedCentre Hospitalier Universitaire Dijon482014-02-042026-02-09
The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine
Metformin, Placebo (for metformin) - Schizophrenia
Phase 4TerminatedSeoul National University Hospital152012-09-012018-09-07
Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section
Silverlon, Standard Dressing - Obesity, Complications; Caesarean Section, Wound
Phase 4TerminatedUniversity of Michigan372012-02-012017-04-04
Liraglutide Use in Prader-Willi Syndrome
Liraglutide - Diabetes Mellitus Type 2, Prader Willi Syndrome
Phase 4TerminatedVancouver General Hospital12012-02-012015-12-09

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Obesity (29)  ·  Diabetes Mellitus, Type 2 (6)  ·  Cardiovascular Diseases (3)  ·  Glucose Intolerance (3)  ·  Metabolic Syndrome (3)  ·  Weight Loss (3)  ·  Hypertension (2)  ·  Pediatric Obesity (2)  ·  Schizophrenia (2)  ·  Acute Kidney Injury (1)  ·  Asthma, Exercise-Induced (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Diabetes Mellitus (1)  ·  Feeding Behavior (1)

Broader conditions

Nutrition Disorders (33)  ·  Nutritional and Metabolic Diseases (33)  ·  Overnutrition (33)  ·  Body Weight (32)  ·  Pathological Conditions, Signs and Symptoms (32)  ·  Signs and Symptoms (32)  ·  Glucose Metabolism Disorders (12)  ·  Metabolic Diseases (12)  ·  Endocrine System Diseases (7)  ·  Diabetes Mellitus (6)  ·  Hyperinsulinism (4)  ·  Body Weight Changes (3)  ·  Hyperglycemia (3)  ·  Insulin Resistance (3)

Interventions

Liraglutide (4)  ·  Metformin (3)  ·  lorcaserin (3)  ·  Orlistat (2)  ·  Sodium Chloride (2)  ·  Sugars (2)  ·  Topiramate (2)  ·  sibutramine (2)  ·  Acarbose (1)  ·  Adiposity (1)  ·  Albuterol (1)  ·  Caloric Restriction (1)  ·  Canagliflozin (1)  ·  Diet Therapy (1)  ·  Diet, Carbohydrate-Restricted (1)

Sponsors

The Cleveland Clinic (2)  ·  Yale University (2)  ·  Albany Medical College (1)  ·  Centre Hospitalier Universitaire Dijon (1)  ·  Columbia University (1)  ·  Duke University (1)  ·  Eisai Inc. (1)  ·  Emory University (1)  ·  Fundación Cardiovascular de Colombia (1)  ·  Hartford Hospital (1)  ·  Hopital Foch (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  New York State Psychiatric Institute (1)  ·  Northwell Health (1)  ·  Ohio State University (1)

Countries

United States (24)  ·  Canada (2)  ·  France (2)  ·  Belgium (1)  ·  Colombia (1)  ·  Denmark (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Alan Ettinger, MD (1)  ·  Alicia L Warnock, MD (1)  ·  Angela Liang, MD (1)  ·  Arne V Astrup, phD.MD (1)  ·  Bartolome Burguera (1)  ·  Cherie Vaz, MD Dipl ABOM (1)  ·  Daniel J Katz, MD (1)  ·  David A Maerz, MD (1)  ·  David L Russell-Jones, MBBS,MD,FRCP (1)  ·  Dharini M Bhammar, Ph.D. (1)  ·  Donna H Ryan, MD (1)  ·  Federico A Silva, MD (1)  ·  Francisco Pasquel, MD, MPH (1)  ·  Gustavo Marques, MD (1)  ·  James AS Muldowney, MD (1)

Results publications

PMID 16959033, PMID 20101009, PMID 21962313, PMID 22445512, PMID 25500680, PMID 25611642, PMID 31405666, PMID 35967820, PMID 36897161, PMID 38686535, PMID 42668311

NIH funding

K23DK074439 (1), K23GM128221 (1), R01DK093920 (1), R01DK105526 (1), R01DK126295 (1)